ArticleJournal of lipid research2014

PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE.

Brandon Ason et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.